Iopamidol

碘帕醇

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameIopamidol
Drug Alias NameIopamidolum碘异酞醇碘必乐碘普罗尔Iopamiron +[12] 
ClassificationSmall moleculesDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionNonionic monomeric iodinated radiographic contrast agents
TargetsNot applicable
Therapy Area/IndicationsContrast agentsCoronary Artery DiseaseProstatic Neoplasms, Castration-Resistant +[5] 
Global Approved IndicationsContrast agents
Approved Indications in ChinaContrast agents
Original Approved Country/TerritoryUnited States
Original Approved Date1985/12/31
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBracco Spa
China Registration ClassN/A

Develop Information

Active CompaniesBracco SpaBayer Healthcare Pharmaceuticals Inc
Inactive CompaniesDuke UniversityBracco Diagnostics Inc
Active IndicationsContrast agents
Inactive IndicationsCoronary Artery DiseaseProstatic Neoplasms, Castration-ResistantCarcinoma, Transitional Cell +[4] 

Other Information

ATC CodeV08AB04
Related LinksWikipediaDrugBankKEGG